## Extracted Text
[Type text]

Project Proposal for

Nebuscent
Deodorizing Aerosol Delivery System & Formulation

Conversion to Manufacturing

Project Number:  23019

The information contained in this Proposal is furnished to Nebuscent in confidence with the understanding that it will not,
without expressed written permission from Slingshot Product Development Group, LLC, be used or disclosed for other
than evaluation purposes; provided, however, that in the event a contract is awarded on the basis of this proposal,
Nebuscent shall have the right to use or disclose the information to the extent allowed in the executed contract.  This
restriction does not limit Nebuscent right to use or disclose this information if obtained from a third party without
restriction.



---

an employee-owned company

May 9th, 2023

Mr. Michael Foley
Founder

NEBUSCENT
1000, Bluff Island Lane
Buford, GA 30518

Phone: 678 982 9555
Email: mfoley@nebuscent.com

Executive Summary

Thank you for considering Slingshot Product Development Group for this program.  Our team is dedicated
to delivering the highest quality product development service possible, and we look forward to helping you
achieve success with this program.

Scope

Phase 3:  Conversion to Manufacturing

Budget

Phase 3: $490,000.00 NRE (Estimated)

Tooling: $450,000-500,000.00 (estimated)

Materials and expenses $20-25,000.00

Total: $960,000.00 - $1,015,000.00 (estimated)

Timeline

Phase 3: 56-60 weeks

Total: 56 to 60 weeks

23019

2



---

an employee-owned company

Project Overview: Deodorizing Aerosol Delivery
System & Formulation

Phase 3 of the project focuses upon refinement of the early Beta prototype and Conversion to
Manufacturing.

Business Goals for this Project

•  Commence Phase-3 by May 15, 2023
•  Limited Production / Field Testing – 50-500 units, June 2024
•  Build Nebuscent Business Aerosol system business

Key Desired Innovations and Differentiators

•  A fully mechanical delivery system for deodorizing aerosol delivery
•  A safe and effective deodorizing formulation
•  A system that eliminates harmful Aerosol propellent chemistry
•  A simple cartridge introduction/removal system
•  A razor/blade business model for cartridge supply to installed delivery system
•

Intellectual Property protecting:

o  Product Development direction
o  Other Product directions identified and protected from competitor exploitation but not

directly pursued

Target Markets

•  North American Healthcare
•  North American Extended Care

23019

3



---

Overview

Nebuscent has worked with Slingshot to date on the following new product development pathway.

an employee-owned company

Project to date

•  Phase 1:

o  Slingshot Brainstormed and Ideated a range of approaches to a mechanical Aerosol delivery

system with no electrical power.

o  Merged and selected most likely solutions.

•  Phase 2A:

o  Slingshot identified two key approaches to viable design directions for a mechanical aerosol

delivery system.

o  Early testing was conducted to identify the leading concept.
o  Leading concept down-selected.
o  Early formulation concepts developed & tested.

•  Phase 2B

o  Slingshot Built advanced Alpha Prototype product mechanism and cartridge to refine early

product mechanism.

o  The advanced Alpha Prototype worked, except the client realized that the unit may be too

expensive to be considered “disposable”.  An alternative "Razor/Razorblade” concept:  with a
durable dispenser and a disposable formulation dispenser was then developed through a
change in scope. to drastically reduce the overall cost per single use.

o  Slingshot incorporated Industrial Design into a functional Beta Design to generate first “looks

like” and “works-like” prototype.

Next Steps

•  Phase 3:

o  Conversion to Manufacturing

Approaches to Avoid

•  No use of CFC aerosol propellent as part of aerosol delivery
•  Delivery System shall receive no electrical power from battery or mains supply
•  No significant solid waste generated during single use aerosol deployment

23019

4



---

an employee-owned company

Project Plan

Phase 3: Conversion to Manufacturing

In Phase-3, Slingshot will refine the ‘design for prototyping’ engineering approach of Phase 2 with a ‘design
for manufacturing’ approach to all of the components in this product assembly.

Slingshot will also refine and simplify the design of the unit mechanism through two iterations of design and
field testing. The unit currently comprises 40 unique parts with a total of 60-75 parts. The purpose of these
steps is to reduce the number of unique parts, simplify the mechanism’s operation and increase its
reliability.

This will be achieved by conducting a progressive ‘controlled conversion’ of parts from their ‘prototype
design version’ to their final production ready design. The effect of introducing these modified parts to the
mechanism will then be progressively monitored through field testing.

Project Planning

•  Kick-off meeting to review project plan.
•  Develop a detailed project schedule and review with Nebuscent

1.  Gamma-1: Prototype Units – (10-Units) => Conversion of first 5-10 parts

•  Refine Industrial Design to accommodate necessary changes identified in earlier (Phase-2B) Beta

iteration

o  Review ID modifications with team and client

•  Convert a selection of parts (10-15) to production ready design

o  Review CAD with team and client
•  Prototype manufacture and test single (1) unit

o  Order & manufacture parts using Beta-Jet/Water Jet route to low volume production (Note:
this approach employs a prototyping resource to create parts manufacturing ready design)
o  Assemble a single unit with converted parts and perform tests one a single unit to confirm

performance.

o  Review test results with team and client.

•  Prototype manufacture and field test 10 units

o  Order and manufacture a selection of parts (10-15) for each of ten (10) units.
o  Assemble ten (10) units

•  Create deodorizing solution for field testing of (10) units
•  Create a semi-automated filling station for the cartridges

o  Field Test (10) units for 2-4 weeks.

•  Review 10-unit field test results with team and client.

o  Provide performance feedback for modification to ‘Gamma-1’ parts.

23019

5



---

an employee-owned company

2.  Gamma-2 Prototype Unit (10-units) => conversion of remaining parts

•  Convert all of the remaining parts (25-30) to production ready design

o  Review CAD with team and client
•  Prototype manufacture and test single (1) unit

o  Order & manufacture parts using Beta-Jet/Water Jet route to low volume production (Note:
this approach employs a prototyping resource to create parts manufacturing ready design)
o  Assemble a single unit with converted parts and perform tests one a single unit to confirm

performance.

o  Review test results with team and client.

•  Prototype manufacture and field test 10 units

o  Order and manufacture a selection of parts (10-15) for each of ten (10) units.
o  Assemble ten (10) units
o
o  Utilize semi-automated filling station for the cartridges
o  Field Test (10) units for 2-4 weeks.

refine deodorizing solution for field testing of (10) units (if refinement is required)

•  Review 10-unit field test results with team and client.

o  Provide performance feedback for modification to ‘Gamma-2’ parts.

3.  Final Product For Large Scale Field test (50-500 Units)

•  Conduct CAD review with primary molding and tooling vendor
•  Modify CAD based upon field test results and Deluxe and forest Feedback

Formulation Development

•  Formulation Batch Development & QC Control

o  Formulation QC

▪  Make (3) separate 1Ib batches

o  Conduct Stability testing on formulation
o

Identify Vendors

▪  Qualify & Select Vendor(s)

o  Schedule Pilot Production

▪  50 Ibs.
▪  100 Ibs.

Assembly Method

•  Develop a Basic Assembly Method for dispenser & Refill Dispenser

o  Review with team and client

Vendor Development

•  Quote package for tooling and convertors

23019

6



---

an employee-owned company

o  Build & send a quotation package to three (3) molders (US & Outside-US)
o  Build & send a quotation package to three (3) assembly houses (US & Outside-US)
o  Work with molders and assemblers during quotation process.
o  Review quotes with team and client
o  Visit and qualify suppliers selected for production molding and assembly(US/DR or other)

•

Implement any additional component Design changes
o  Determine forward path of design changes
o  Modify Design of Product and parts as required from review meeting

•  Order prototype molds (P20-Steel)
o  Tool build by vendors

Packaging Development

•  Develop packaging for dispenser and refill unit
•  Develop Packaging graphics

First Manufactured Unit Assemblies

•  Review first parts off tooling

o  Team and Client
o  Modify Molds as required

•  Review final shots of tooling
o  Team & Client

•  Build first product assemblies (5) from molded parts

Product Performance/Durability Testing

•

Identify and develop a durability test that provides a realistic quantification of product performance
during extended use.

o  Design & Build Unit durability testing module
o  Conduct durability testing on statistically sampled units assembled from high volume

manufactured components.

o  Review durability tests with team and client.

Limited Production Run

•  Select final resources for 50–500-unit production manufacture and assembly
•  Place purchase order (PO) for 50-500 unit production
•  Assemble and package Production units
•  Field test Production Units.

23019

7



---

an employee-owned company

 Additional Services

Quality Assurance System Development

•  Communicate Product Specification; testing and quality control requirement to manufacturer(s).
•  Create quality control Documentation with manufacturers identifying:

o  System of quality control and tests to be performed
o  Statistical Quality Control standard for production lots.

Not included at this time (but can be added)

Item not included is large scale-up cartridge manufacturing assembly and fill unit.

This unit can be planned during this phase of work and executed in a separate scope of work following
successful field trials.

Deliverable Examples:

23019

8



---

an employee-owned company

Deliverables

Phase 3 Deliverables

•  Project Plan
•  Timeline with breakdown of individual steps in Phase 3

Formulation Batches

•  Formulation Batch Development & QC Control

o  Formulation evaluation of (3) separate 1Ib batches
o  Stability testing report and conclusion
o  Report Identifying Qualified Vendor(s)
o  Scheduled Formulation Pilot Batch Production

▪  50 Ibs.
▪  100 Ibs.

1.  Gamma-1 Prototype Units

•  Gamma-1 Prototype Units (10 units fully assembled) – with 10-15 production designed parts

o  CAD for modified parts including tolerancing of performance critical parts.

•  Semi-automated filling station for cartridges

o  Suitable to create sufficient cartridges to permit field testing of 10-prototype units E.g 200-

cartridges

•  Filled Cartridges: up to 200 units (more available upon request).

2.  Gamma-2 Prototype Units

•  Gamma-2 Prototype units (10 units fully assembled) with remaining production designed parts

o  CAD for modified parts including tolerancing of performance critical parts.

•  Filled Cartridges: up to 200 units (more available upon request).

3.  Final Product for Large Scale Field test (50-500 Units)

•  Final CAD for release to component manufacturer(s) with tolerancing of performance critical parts.

Assembly Method

•  Assembly Method documentation for vendor review.
•

Identification and down-selection of key manufacturer and product assembly / cartridge fill source.

23019

9



---

Vendor Development

•  Vendor Information packages for Tooling, Molder and assembly houses
•  Qualify and down-select vendors
•  Order prototype molds (P20) steel

an employee-owned company

Packaging Development

•  Packaging design for dispenser and refill unit
•  Packaging graphics

First Manufactured Unit Assemblies

•  Review first parts off tooling
•  Build and deliver first five (5) product assemblies.

Product Performance/Durability Testing

•  Design and Build durability testing module
•  Conduct durability testing on statistically sampled units

Limited Production Run

•  Select final Manufacturing resources
•  Place Purchase order of 50-500 units.

23019

10



---

an employee-owned company

Project Schedule

A specific project schedule will be created when the project is engaged.  The following guidelines are
expected to form the basis of that schedule.

A detailed timeline will be presented separately in an Excel Spreadsheet to accompany this document.

23019

11



---

an employee-owned company

Project Parameters

Project Assumptions

The budget and timeline proposed for this project is based on the following assumptions.

•  Any changes to the project plan may incur additional budget and schedule.  Significant changes will

be documented with a project change form.

•  Typically, prototypes will be suitable for a subjective level of testing to confirm design direction and

intent, but will not be suitable for third party, government, or agency testing.

•  This is an interactive project between Slingshot and Nebuscent.  Regular interaction and feedback

will be critical to achieving project goals and schedule.  Client personnel will be reasonably available
for reviews and to provide feedback at key milestones during the program.

•  This proposal assumes a regular customer conference call or meeting of 1 hour per week with the

project manager and one key project team member as required.

•  Slingshot will have access to/communication with appropriate personnel from any third-party

working on project as needed;  It is assumed that third-party will cooperate fully with Slingshot as
needed for the project and that Slingshot will represent Client’s interests in all communications
•  Unless specifically stated otherwise, Client is responsible for the accuracy of any data provided to

Slingshot and data is assumed to be most current

•  Client is responsible to provide any information regarding the target market, business goals for this
product, existing designs and CAD, and other internal information that may influence design and
engineering strategy.

Project Scope

Activities in scope for the quoted phases of this project include:

•  Product Design / Engineering
•  Gamma Prototyping
•  Optimizing for Manufacturing
•  Pilot Production / Low Volume – Full Scale Manufacturing

Activities not included in the scope of this project include the following list.  Slingshot can assist with many
of these tasks in additional scopes of work

•

Item not included is large scale-up cartridge manufacturing assembly and fill unit. [This unit can be
planned during this phase of work and executed in a separate scope of work following successful
field trials].

23019

12



---

Budget and Payment Schedule

Phase 3 Budget

an employee-owned company

Product Development Work

$490,000.00

Tooling Estimate (Pass-through)

$450,000.00-500,000.00

Materials and Expenses (estimated)

$20,000.00-25,000.00

TOTAL

$960,000.00-
$1,015.000.00

Phase 1 Payment Schedule

Payment to commence (development work)

$245,000.00

Materials and Expense Deposit

$25,000.00

To Commence Project

$270,000.00

This is a time and materials phase of work. The expended hours and materials budget will be billed
monthly and reconciled against the deposit. Once the deposit is consumed then billing will occur
monthly.

Materials / Expenses Reconciliation due at Project Completion

TBD credit or additional due

Please note that materials, travel, tooling and other expenses will be billed at cost plus a 10% administrative fee.  Expense amounts
listed above are estimates and may vary during the project.  As applicable, anticipated costs and options will be presented to the
client during the program for review and approval.  Some suppliers may require 100% payment prior to delivery of parts, and
therefore additional funds may be requested prior to delivery of parts and components to Slingshot.  Unused materials funds will be
returned or credited.

23019

13



---

an employee-owned company

Commissioning Statement

This proposal, 23019, constitutes an offer to provide product development services.  Please indicate your
acceptance of this project and associated terms by signing this Commissioning Document and returning it
with applicable payment (checks payable to Slingshot Product Development Group, LLC).  The signed form
may be delivered via email, or faxed to nigelf@slingshotpdg.com

By signing this page, you acknowledge that you have read this proposal and that you understand the
terms, conditions, and payment schedule.  This includes the client’s responsibility for a 10% administrative
fee for materials and project expenses, as well as possible late fees and a cancellation fee as described in
the Terms and Conditions section of this document.

Client: Nebuscent
Project: Deodorizing Aerosol Delivery System & Formulation  (Conversion to Manufacturing)
Project Phases Being Commissioned: Phases 3
Project Costs: $490,000.00 Product Development
Expenses: $20,000.00-25,000.00 (estimate)
Tooling: $450,000.00-500,000.00
Total Project Cost for Commissioned Phases: $960,000.00-$1,015,000.00 (estimate)
Due to commence this project: $270,000.00

I acknowledge the above referenced scope and costs.  Slingshot is commissioned to begin work on the project.

Date:  __________________________________________

Name: _________________________________________

Title: __________________________________________

Signature:______________________________________

PO Number (if applicable): ________________________

Shipper Name* / Account #: ________________________

This proposal expired 30 days from the date of issue.  The schedule provided in this proposal is an estimated schedule.  Immediate
payment is requested for the commencement amount.  Payment terms on other payments are net 30 days. Delays in payment of
material deposits may result in added schedule.

*Please include your preferred shipping carrier (Fedex, UPS) and account number if you would like any shipping billed directly to
your account.

Please sign and date this commissioning statement, and return via email to nigelf@slingshotpdg.com

23019

14



---

an employee-owned company

Future Work and Additional Phases

Beyond the scope quoted in this proposal, Slingshot can assist with a number of product development
activities including manufacturing and logistics.  Such additional phases can be quoted or estimated as
desired.

Some specific future phases include:

•  Large scale-up cartridge manufacturing assembly and fill unit.

[This unit can be planned during this phase of work and executed in a separate scope of work following
successful field trials].

•  Manufacturing
•  Logistics.

23019

15



---

an employee-owned company

Appendix A: Multi-Disciplined Approach

Slingshot approaches product development from a polymath perspective, and our team is comprised of
talented professionals from many different disciplines. Our clients benefit from the multiple perspectives
provided by the Slingshot team, and the diversity of our team leads to faster, more effective product
launches.

Science and Technology Development

Slingshot has deep expertise in material science, chemistry, biological science, and scientific research
methods.  Our science team is focused on launching market-changing technologies and products on time,
and under budget.

Industrial Design

Slingshot’s award winning industrial design team plays a critical role in many of our clients’ product
development programs.  Of course our designers have a highly developed sensitivity to good aesthetics and
form, but unlike a “pure design firm”, our team also has a high level of technical sensibility. We work hard
to ensure that your product concepts combine the excitement of inspired design with the practicality of
manufacturability and cost sensitivity.

Product Engineering

Slingshot’s engineering team is thorough, fast, and detail oriented; all traits that are critical for a successful
product launch. Our team includes a combination of mechanical engineers, electrical engineers, biomedical
engineers, and manufacturing experts.

Manufacturing and Logistics

Slingshot combines the strength of rigorous product development process with a powerful international
manufacturing and sourcing service. Through our optimization processes and hundreds of properly audited
suppliers, Slingshot gives you better products at lower prices.

23019

16



---

an employee-owned company

Appendix B: Slingshot’s Record of Success

Slingshot is an innovation company, and we build product businesses.  Our integrated, multi-disciplinary
team of researchers, designers, engineers, and scientists work in tight collaboration to launch successful
new innovations.  Slingshot innovates with hundreds of clients, including many of the world’s leading
brands and companies.  Some of the brands and companies that Slingshot has innovated with include (all
logos and trademarks are the property of their respective owners):

23019

17



---

an employee-owned company

Appendix C: Terms and Conditions

1 .   A G R E E M E N T .   T h i s   Q u o t a t i o n   i s   a n   o f f e r   b y   S l i n g s h o t   P r o d u c t   L a b ,   L . L . C .   ( S l i n g s h o t ) ,   t o   s e l l   t h e   s e r v i c e s   d e s c r i b e d   h e r e i n   a n d   i s
e x p r e s s l y   c o n d i t i o n e d   u p o n   C l i e n t ' s   a c c e p t a n c e   t o   b i n d   S l i n g s h o t .     B y   a c c e p t i n g   t h i s   o f f e r ,   C l i e n t   a g r e e s   t o   a n d   a c c e p t s   a l l   t h e s e   t e r m s   a n d
c o n d i t i o n s   a n d   a g r e e s   t h a t   t h e y   s u p e r s e d e   a n d   r e p l a c e   a n y   a n d   a l l   c o n f l i c t i n g   t e r m s   a n d   c o n d i t i o n s   i n   a n y   o t h e r   d o c u m e n t .   C l i e n t   e x p r e s s l y
w a i v e s   a n y   a d d i t i o n a l   o r   d i f f e r e n t   t e r m s   a n d   c o n d i t i o n s   b y   a c c e p t a n c e   o f   a n y   s e r v i c e s   p r o v i d e d   p u r s u a n t   t o   t h i s   A g r e e m e n t ,   a n d   a g r e e s   t h a t
a n y   s u c h   a d d i t i o n a l   o r   d i f f e r e n t   t e r m s   a n d   c o n d i t i o n s   s h a l l   h a v e   n o   e f f e c t

C l i e n t  d e m o n s t r a t e s  i t s  a c c e p t a n c e  o f  t h e s e  t e r m s  a n d  c o n d i t i o n s   w h e n  C l i e n t  ( 1 )  i n  w r i t i n g ,  b y  f a c s i m i l e  t r a n s m i t t a l ,  o r  o t h e r w i s e  a u t h o r i z e s
S l i n g s h o t   t o   p e r f o r m   a n y   o f   t h e   w o r k   d e s c r i b e d   i n   t h i s   A g r e e m e n t .     T h i s   d o c u m e n t   c o n s t i t u t e s   t h e   e n t i r e   a g r e e m e n t   ( " A g r e e m e n t " )   b e t w e e n
S l i n g s h o t   a n d   C l i e n t   a n d   s u p e r s e d e s   a l l   p r e v i o u s   w r i t t e n   o r   o r a l   a g r e e m e n t s   o r   u n d e r s t a n d i n g s   b e t w e e n   t h e   p a r t i e s   w i t h   r e s p e c t   t o   t h e
s u b j e c t   m a t t e r   o f   t h i s   A g r e e m e n t .     T h e   C l i e n t   m a y   n o t   a s s i g n   t h e   b e n e f i t   o f   t h i s   A g r e e m e n t   w i t h o u t   t h e   e x p r e s s   p r i o r   w r i t t e n   c o n s e n t   o f
S l i n g s h o t .     A n y   p r o v i s i o n   o f   t h i s   A g r e e m e n t   t h a t   i s   o r   m a y   b e   p r o h i b i t e d   o r   u n e n f o r c e a b l e   u n d e r   a p p l i c a b l e   l a w   s h a l l   b e   i n e f f e c t i v e   o n l y   t o
t h e   e x t e n t   i t   i s   p r o h i b i t e d   a n d   u n e n f o r c e a b l e   a n d   s h a l l   n o t   i n v a l i d a t e   t h e   r e m a i n i n g   p r o v i s i o n s   o f   t h i s   A g r e e m e n t .

N o   o r d e r   m a y   b e   c a n c e l e d   o r   a l t e r e d   b y   C l i e n t   e x c e p t   w i t h   S l i n g s h o t ' s   e x p r e s s   p r i o r   w r i t t e n   c o n s e n t .

C l i e n t  a c k n o w l e d g e s   t h a t  t h e   w o r k   S l i n g s h o t   p e r f o r m s  p u r s u a n t   t o  t h i s   A g r e e m e n t  i s  a  s e r v i c e ,   e v e n   t h o u g h   S l i n g s h o t  m a y   p r o d u c e  a   p r o d u c t
i n   c o n j u n c t i o n   w i t h   t h a t   s e r v i c e .

C l i e n t   a c k n o w l e d g e s   t h a t   d e l i v e r y   d a t e s   i n   t h e   Q u o t a t i o n   a r e   e s t i m a t e d   a n d   a r e   n o t   i n t e n d e d   t o   b i n d   S l i n g s h o t .     C l i e n t ’ s   a c c e p t a n c e   o f
s e r v i c e s   p u r s u a n t   t o   t h e   A g r e e m e n t   w i t h o u t   s u b m i t t i n g   a   c o m p l a i n t   w i t h i n   t e n   ( 1 0 )   d a y s   a f t e r   s u c h   a c c e p t a n c e   c o n s t i t u t e s   a d m i s s i o n   b y   t h e
C l i e n t   o f   S l i n g s h o t ' s   s a t i s f a c t i o n   o f   i t s   o b l i g a t i o n s   t o   C l i e n t .     S l i n g s h o t   s h a l l   n o t   b e   l i a b l e   f o r   a n y   d a m a g e   r e s u l t i n g   f r o m   a n y   c a u s e   b e y o n d
S l i n g s h o t ' s   c o n t r o l ,   i n c l u d i n g ,   w i t h o u t   l i m i t a t i o n ,   a n   a c t   o f   G o d ,   a c t   o f   t h e   C l i e n t ,   e m b a r g o   o r   t h e   g o v e r n m e n t   a c t ,   r e g u l a t i o n   o r   r e q u e s t ,
f i r e ,   a c c i d e n t ,   s t r i k e ,   s l o w d o w n ,   w a r ,   d e l a y   i n   t r a n s p o r t a t i o n ,   i n a b i l i t y   t o   o b t a i n   n e c e s s a r y   l a b o r ,   m a t e r i a l s ,   o r   m a n u f a c t u r i n g   f a c i l i t i e s .

2 .     R I G H T   T O   C H A N G E S .   S l i n g s h o t   h a s   t h e   r i g h t   t o   c a n c e l   a n d   d e c l a r e   t h i s   A g r e e m e n t   n u l l   a n d   v o i d   w i t h o u t   l i a b i l i t y   t o   t h e   C l i e n t   o t h e r
t h a n   r e f u n d i n g   t o   C l i e n t   a n y   p a y m e n t   f o r   s e r v i c e s   n o t   p e r f o r m e d   p r i o r   t o   c a n c e l l a t i o n .     A n y   c h a n g e s   i n   d r a w i n g s ,   m a t e r i a l s ,   d e s i g n
s p e c i f i c a t i o n s ,   o r   m a s t e r s   w h i c h   a f f e c t   t h e   s c o p e   o f   t h e   p r o j e c t   w i l l   e n t i t l e   S l i n g s h o t   t o   e s t a b l i s h   n e w   p r i c e s ,   a n d   i f   w o r k   h a s   b e e n   s t a r t e d ,
S l i n g s h o t   s h a l l   b e   p r o p e r l y   r e i m b u r s e d   f o r   w o r k   a l r e a d y   p e r f o r m e d   i f   t h e   w o r k   w a s   a p p r o v e d   b y   t h e   c l i e n t .     C l i e n t   h a s   t h e   r i g h t   t o   c a n c e l
a   p r o g r a m   a t   a n y   t i m e   b y   t e n   ( 1 0 )   d a y s   w r i t t e n   n o t i c e   t o   S l i n g s h o t .     T h e   C l i e n t   r e m a i n s   o b l i g a t e d   t o   p a y   f o r   w o r k   p e r f o r m e d   a n d   e x p e n s e s
i n c u r r e d   t h r o u g h   t h e   d a t e   t h a t   t h e   c a n c e l l a t i o n   n o t i c e   i s   r e c e i v e d   b y   S l i n g s h o t   p l u s   a   c a n c e l l a t i o n   c h a r g e   e q u a l   t o   2 5 %   o f   t h e   q u o t e d   f e e
f o r   t h e   c a n c e l e d   p r o g r a m .

3 .     P A Y M E N T .   P r i o r   t o   c o m m e n c e m e n t   o f   w o r k ,   C l i e n t   w i l l   d e p o s i t   5 0 %   o f   t h e   q u o t e d   f e e   w i t h   S l i n g s h o t ,   w i t h   p r o g r e s s   b i l l i n g   f o r   t h e
b a l a n c e .     A l l   i n v o i c e s   a r e   p a y a b l e   w i t h i n   t h i r t y   ( 3 0 )   d a y s   o f   r e c e i p t   o f   e a c h   i n v o i c e   u n l e s s   e x p r e s s l y   n e g o t i a t e d   a n d   d o c u m e n t e d   i n   a d v a n c e
o f   t h i s   A g r e e m e n t .     I n v o i c e s   a r e   d u e   a n d   p a y a b l e   b y   t h e   t e r m s   d e s c r i b e d   o n   e a c h   i n v o i c e   ( " d u e   d a t e " ) .     A n y   a m o u n t   n o t   p a i d   b y   t h e   d u e   d a t e
s h a l l   b e   s u b j e c t   t o   a   f i n a n c e   c h a r g e   o f   1 . 5 %   ( o r   t h e   g r e a t e s t   a m o u n t   a l l o w e d   b y   s t a t e   l a w )   a s s e s s e d   e a c h   m o n t h   u n t i l   t h e   b a l a n c e   i s   p a i d   i n
f u l l .     C l i e n t   a g r e e s   t o   p a y   a l l   o f   S l i n g s h o t ' s   a t t o r n e y   f e e s ,   c o l l e c t i o n   f e e s   a n d   c o s t s   a r i s i n g   f r o m   a n y   b r e a c h   b y   C l i e n t   o f   t h i s   o r   a n y
s u b s e q u e n t   Q u o t a t i o n   o r   A g r e e m e n t .     S l i n g s h o t   s h a l l   n o t   b e   o b l i g a t e d   t o   p e r f o r m   u p o n   a n y   o r d e r   u n t i l   S l i n g s h o t   r e c e i v e s   t h e   r e q u i s i t e
d e p o s i t .   P a y m e n t s   w i l l   b e   c r e d i t e d   ﬁ r s t   t o   l a t e   p a y m e n t   c h a r g e s   a n d   n e x t   t o   t h e   u n p a i d   b a l a n c e .   S l i n g s h o t   P r o d u c t   L a b   L . L . C . ,   a t   i t s   s o l e
d i s c r e t i o n ,   r e s e r v e s   t h e   r i g h t   t o   c e a s e   w o r k   i f   p a y m e n t   i s   n o t   r e c e i v e d   w i t h i n   t h e   a g r e e d - u p o n   p a y m e n t   p e r i o d .   C l i e n t   s h a l l   b e   r e s p o n s i b l e
f o r   a l l   c o l l e c t i o n   a n d / o r   l e g a l   f e e s   n e c e s s i t a t e d   b y   l a t e n e s s   o r   d e f a u l t   i n   p a y m e n t .     A m o u n t s   h e l d   o n   d e p o s i t   s h a l l   n o t   b e a r   i n t e r e s t .   A l l
p r i c e s   q u o t e d   s h a l l   b e   e x c l u s i v e   o f   t r a n s p o r t a t i o n   f r o m   t h e   F . O . B .   p o i n t ,   i n s u r a n c e ,   t a x e s ,   l i c e n s e   f e e s ,   c u s t o m s   f e e s ,   d u t i e s   a n d   o t h e r
c h a r g e s  r e l a t e d  t h e r e t o .     I f   S l i n g s h o t   p a y s   a n y  s u c h  s h i p p i n g  c h a r g e s ,   p r e m i u m s ,  t a x e s ,   f e e s ,   d u t i e s ,   a n d  o t h e r   c h a r g e s ,   C l i e n t  w i l l  p r o m p t l y
r e i m b u r s e   S l i n g s h o t   f o r   t h o s e   e x p e n s e s .     C l i e n t   s h a l l   r e p o r t   a n d   p a y   a n y   a n d   a l l   s u c h   s h i p p i n g   c h a r g e s ,   p r e m i u m s ,   t a x e s ,   f e e s ,   d u t i e s ,   a n d
o t h e r   c h a r g e s   r e l a t e d   t h e r e t o   a n d   s h a l l   h o l d   S l i n g s h o t   h a r m l e s s   f r o m   t h e m .   S l i n g s h o t   P r o d u c t   L a b   L . L . C .   r e s e r v e s   t h e   r i g h t   t o   w i t h h o l d
d e l i v e r y   a n d   a n y   t r a n s f e r   o f   o w n e r s h i p   o f   a n y   c u r r e n t   w o r k   i f   a c c o u n t s   a r e   n o t   c u r r e n t   o r   o v e r d u e   i n v o i c e s   a r e   n o t   p a i d   i n   f u l l .   A l l   g r a n t s
o f  a n y  l i c e n s e  t o  u s e  o r  t r a n s f e r  o f  o w n e r s h i p  o f  a n y  i n t e l l e c t u a l  p r o p e r t y  r i g h t s  ( d e s i g n  a n d / o r  u t i l i t y )  u n d e r  t h i s  A g r e e m e n t  a r e  c o n d i t i o n e d
u p o n   r e c e i p t   o f   p a y m e n t   i n   f u l l   w h i c h   s h a l l   b e   i n c l u s i v e   o f   a n y   a n d   a l l   o u t s t a n d i n g   A d d i t i o n a l   C o s t s ,   T a x e s ,   E x p e n s e s ,   a n d   F e e s ,   C h a r g e s ,
o r   t h e   c o s t s   o f   C h a n g e s .   F i n a l   p a y m e n t   t e r m s   s u b j e c t   t o   c r e d i t   a p p r o v a l

4 .    P A T E N T S ,  C O P Y R I G H T S :  A P P R O V A L .  S l i n g s h o t  n e i t h e r  w a r r a n t s  n o r  r e p r e s e n t s  t h a t  a n y  s e r v i c e s  f u r n i s h e d  h e r e u n d e r  m a y  c r e a t e  r i g h t s ,
w h i c h   m a y   b e   p a t e n t a b l e   o r   c o p y r i g h t a b l e .     C l i e n t   s h a l l   r e v i e w   a n d   a p p r o v e   a l l   p l a n s ,   d r a w i n g s ,   s k e t c h e s ,   r e n d e r i n g s ,   d i a g r a m s ,
s p e c i f i c a t i o n s ,  m o d e l s , a n d  p r o t o t y p e s  p r e p a r e d  f o r  C l i e n t  b y  S l i n g s h o t  ( c o l l e c t i v e l y  " d e s i g n  w o r k " ) .    S u c h  a p p r o v a l  s h a l l  c o n s t i t u t e  C l i e n t ' s
w a r r a n t y   a n d   r e p r e s e n t a t i o n   t o   S l i n g s h o t   t h a t   n o   d e s i g n   w o r k   o r   p r o d u c t   p r o d u c e d   b y   S l i n g s h o t   f o r   C l i e n t   i n f r i n g e s   u p o n   a n y   p a t e n t ,
c o p y r i g h t ,   o r   t r a d e   s e c r e t .     C l i e n t   a c k n o w l e d g e s   t h a t   S l i n g s h o t   i s   r e l y i n g   u p o n   C l i e n t ' s   r e p r e s e n t a t i o n s   h e r e i n   a n d   t h a t   S l i n g s h o t   h a s   n o t
m a d e ,   a n d   i s   n o t   o b l i g a t e d   t o   m a k e ,   a n y   i n d e p e n d e n t   i n q u i r y   o r   i n v e s t i g a t i o n .     U p o n   r e c e i p t   b y   S l i n g s h o t   o f   a l l   p a y m e n t s   d u e   u n d e r   t h i s
A g r e e m e n t ,   a l l   f i n a l   d e s i g n s   o r   c o n c e p t s   p r e s e n t e d   b y   S l i n g s h o t   u n d e r   t h i s   A g r e e m e n t   w i l l   b e c o m e   t h e   p r o p e r t y   o f   t h e   C l i e n t .     S l i n g s h o t   w i l l
a s s i s t   t h e   C l i e n t   i n   p r o t e c t i n g   a n y   p r o p r i e t a r y   r i g h t s   h e r e i n   u p o n   r e i m b u r s e m e n t   o f   i t s   c h a r g e s   f o r   t i m e   a n d   e x p e n s e s .

5 .     I N D E M N I F I C A T I O N .   C l i e n t   w i l l   i n d e m n i f y   a n d   h o l d   h a r m l e s s   S l i n g s h o t   f r o m   a n d   a g a i n s t   a n y   a n d   a l l   p r o d u c t   l i a b i l i t y   c l a i m s ,   i n c l u d i n g
b u t   n o t   l i m i t e d   t o   a n y   a n d   a l l   c l a i m s   f o r   p e r s o n a l   i n j u r i e s   o r   p r o p e r t y   d a m a g e s   c a u s e d   b y   a n y   a l l e g e d   d e f e c t   i n   a n y   p r o d u c t .     C l i e n t
u n d e r s t a n d s   t h a t   S l i n g s h o t   w i l l   p e r f o r m   n o   p r o d u c t s   t e s t i n g   a n d   t h a t   S l i n g s h o t   i s   n o t   r e s p o n s i b l e   f o r   p r o v i d i n g   a n y   w r i t t e n   w a r n i n g s   o r

23019

18



---

an employee-owned company

i n s t r u c t i o n s   t o   C l i e n t   o r   a n y   o t h e r   p a r t y .       S l i n g s h o t   w i l l   m a k e   r e a s o n a b l e   e f f o r t s   t o   m e e t   d e s i g n   s p e c i f i c a t i o n s   a s   s e t   f o r t h   b y   C l i e n t   b u t
C l i e n t   i s   n o t   r e l y i n g   o n   a n y   a d v i c e   g i v e n   b y   S l i n g s h o t   c o n c e r n i n g   s a f e t y   o r   t e s t i n g   o f   t h e   p r o d u c t s .       C l i e n t   s h a l l   o b t a i n   a n d   m a i n t a i n
p r o d u c t   l i a b i l i t y   i n s u r a n c e   c o v e r a g e   i n   a   s u f f i c i e n t   a m o u n t   t o   c o v e r   a l l   p r o d u c t   l i a b i l i t y   e x p o s u r e ,   w h i c h   i n s u r a n c e   s h a l l   b e   p r i m a r y   f o r
a n y   c l a i m   a r i s i n g   o u t   o f   a   p r o d u c t .     W h e n   r e q u e s t e d   b y   S l i n g s h o t ,   C l i e n t   a g r e e s   t o   p r o v i d e   S l i n g s h o t   w i t h   a   c e r t i f i c a t e   o f   i n s u r a n c e   n a m i n g
S l i n g s h o t   a s   a n   a d d i t i o n a l   i n s u r e d   b e f o r e   a n y   f i n a l   p a r t s   o r   d e s i g n   i s   c o m p l e t e d .   C l i e n t   w i l l   i n d e m n i f y   a n d   h o l d   h a r m l e s s   S l i n g s h o t   f r o m
a n d   a g a i n s t   a n y   c l a i m   t h a t   t h e   d e s i g n   w o r k   c o n t e m p l a t e d   b y   t h i s   A g r e e m e n t   t h a t   v i o l a t e s   a n y   p a t e n t ,   t r a d e m a r k   o r   o t h e r   p r o p r i e t a r y   r i g h t s .
E x c e p t   a s   o t h e r w i s e   s p e c i f i c a l l y   p r o v i d e d   i n   w r i t i n g   f r o m   S l i n g s h o t   t o   c l i e n t ,   S l i n g s h o t   m a k e s   n o   w a r r a n t i e s   w i t h   r e s p e c t   t o   t h e
g o o d s / s e r v i c e s   c o v e r e d   h e r e u n d e r ,   a n d   S l i n g s h o t   e x p r e s s l y   d i s c l a i m s   a n y   a n d   a l l   w a r r a n t i e s ,   e x p r e s s ,   s t a t u t o r y   o r   i m p l i e d ,   i n c l u d i n g   t h o s e
o f   m e r c h a n t a b i l i t y   a n d   o f   f i t n e s s   f o r   a n y   p a r t i c u l a r   p u r p o s e .     T h i s   i s   a   c o n t r a c t   f o r   s e r v i c e s ,   a n d   t h e   C l i e n t   a g r e e s   t h e r e f o r e   t h a t   n o n e   o f
t h o s e   w a r r a n t i e s   a p p l y .     T h e   p a r t i e s   t o   t h i s   A g r e e m e n t   i n t e n d   f o r   t h i s   i n d e m n i t y   p r o v i s i o n   t o   s u r v i v e   t h e   e x p i r a t i o n   o f   t h i s   A g r e e m e n t .

6 .     L I M I T A T I O N   O F   L I A B I L I T Y .   S l i n g s h o t   s h a l l   n o t   b e   l i a b l e   t o   t h e   C l i e n t   o r   a n y   o t h e r   p e r s o n   o r   e n t i t y   f o r   s p e c i a l ,   i n c i d e n t a l ,   e x e m p l a r y ,
p u n i t i v e   o r   c o n s e q u e n t i a l   d a m a g e s   r e s u l t i n g   f r o m   S l i n g s h o t ’ s   d e f a u l t   o r   b r e a c h   o f   t h i s   A g r e e m e n t .     T h o s e   d a m a g e s   s h a l l   i n c l u d e ,   b u t   n o t
b e   l i m i t e d   t o ,   l o s s   o f   o t h e r   p r o p e r t y   o r   e q u i p m e n t ,   l o s s   o f   p r o f i t s   o r   r e v e n u e ,   c o s t   o f   c a p i t a l   o r   c l a i m s   f o r   s e r v i c e   i n t e r r u p t i o n s .     T h e
r e m e d i e s   o f   t h e   C l i e n t   s e t   f o r t h   h e r e i n   a r e   e x c l u s i v e ,   a n d   t h e   l i a b i l i t y   o f   S l i n g s h o t   w i t h   r e s p e c t   t o   t h e   Q u o t a t i o n ,   o r   a n y t h i n g   d o n e   i n
c o n n e c t i o n   w i t h   t h i s   A g r e e m e n t   s u c h   a s   t h e   p e r f o r m a n c e   o r   b r e a c h   t h e r e o f ,   o r   f r o m   t h e   p e r f o r m a n c e ,   m a n u f a c t u r e   o r   s a l e ,   d e l i v e r y   o f   a n y
p r o d u c t  o r  s e r v i c e  c o v e r e d  b y  o r  f u r n i s h e d  u n d e r  t h i s  q u o t a t i o n ,  w h e t h e r  i n  c o n t a c t ,   t o r t ,  u n d e r  a n y  w a r r a n t y ,  o r  o t h e r w i s e ,  s h a l l  n o t  e x c e e d
t h e   p a y m e n t s   r e c e i v e d   b y   S l i n g s h o t   f r o m   t h e   C l i e n t   f o r   t h e   s e r v i c e   o n   w h i c h   s u c h   l i a b i l i t y   i s   b a s e d .     T h i s   l i m i t a t i o n   s h a l l   a p p l y   w h e t h e r   o r
n o t   t h e   C l i e n t   o r   a n o t h e r   p a r t y   h a s   b e e n   a d v i s e d   o f   t h e   p o s s i b i l i t y   o f   a n y   o t h e r   d a m a g e s .     T h e   p a r t i e s   t o   t h i s   a g r e e m e n t   i n t e n d   f o r   t h i s
l i m i t a t i o n   o f   l i a b i l i t y   p r o v i s i o n   t o   s e r v e   t h e   e x p i r a t i o n   o f   t h i s   a g r e e m e n t .

7 .   P R O F E S S I O N A L   C R E D I T .   U n l e s s   o t h e r w i s e   s p e c i f i e d ,   o n c e   t h e   p r o j e c t   c o n t e m p l a t e d   b y   t h i s   A g r e e m e n t   h a s   b e e n   l a w f u l l y   i n t r o d u c e d   t o
o t h e r s  i n  t h e  i n d u s t r y ,  o r  t h e  g e n e r a l  p u b l i c ,  S l i n g s h o t  s h a l l  h a v e  t h e  r i g h t  t o  i n c l u d e  p h o t o g r a p h i c  o r  a r t i s t i c  r e p r e s e n t a t i o n s  o f  t h e  p r o j e c t
a m o n g  S l i n g s h o t ’ s  p r o m o t i o n a l ,  p r o f e s s i o n a l ,  a n d  c o n t e s t  s u b m i s s i o n  m a t e r i a l s .  S l i n g s h o t ’ s  m a t e r i a l s  s h a l l  n o t  i n c l u d e  C l i e n t ’ s  c o n f i d e n t i a l
o r   p r o p r i e t a r y   i n f o r m a t i o n .

8 .    N O  W A I V E R .  N o  p r o v i s i o n  h e r e o f  a n d  n o  b r e a c h  o f  a n y  p r o v i s i o n  h e r e o f  s h a l l  b e  d e e m e d  w a i v e d  b y  a n y  p r e v i o u s  w a i v e r  o f  s u c h  p r o v i s i o n
o r   o f   a n y   b r e a c h   t h e r e o f ,   b y   a n y   p r e v i o u s   c u s t o m ,   p r a c t i c e ,   o r   c o u r s e   o f   d e a l i n g   o r   b y   S l i n g s h o t ' s   f a i l u r e   t o   o b j e c t   t o   p r o v i s i o n s   c o n t a i n e d
i n   a n y   c o m m u n i c a t i o n   o r d e r   f r o m   C l i e n t .

9 .   S T A T U E   O F   L I M I T A T I O N .   N o   a c t i o n   a r i s i n g   o u t   o f ,   i n   c o n n e c t i o n   w i t h ,   o r   r e l a t i n g   t o   t h i s   A g r e e m e n t   o r   t h e   s u b j e c t   o f   t h i s   A g r e e m e n t
s h a l l   b e   b r o u g h t   m o r e   t h a n   o n e   ( 1 )   y e a r   a f t e r   t h e   C l i e n t ’ s   f i r s t   a c t u a l   o r   c o n s t r u c t i v e   n o t i c e   t h a t   a   c a u s e   o f   a c t i o n   m a y   h a v e   a c c r u e d .     T h i s
p e r i o d   s h a l l   n o t   b e   e x t e n d e d   f o r   a n y   r e a s o n ,   e x c e p t   b y   t h e   w r i t t e n   c o n s e n t   o f   b o t h   p a r t i e s .       A l l   s t a t u t e s   o r   p r o v i s i o n s   o f   l a w   w h i c h   w o u l d
t o l l   o r   o t h e r w i s e   a f f e c t   t h e   r u n n i n g   o f   t h e   p e r i o d   o f   l i m i t a t i o n   a r e   h e r e b y   w a i v e d ,   a n d   n o   s u c h   s t a t u t e   o r   p r o v i s i o n   o f   l a w   s h a l l   o p e r a t e   t o
e x t e n d   t h e   p e r i o d   l i m i t e d   i n   t h i s   p a r a g r a p h .

23019

19



## LLM Analysis
*Content processed with Microsoft MarkItDown - structure-preserving markdown conversion optimized for LLM consumption. MarkItDown automatically maintains document hierarchy, tables, and formatting.*
